NIH-funded research NIH-funded research

Alzheimer’s and related dementia in older adults with prediabetes or type 2 diabetes

Official title: Alzheimer's Disease and Alzheimer's Disease Related Dementias in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Outcomes Study AD/ADRD Project

Funded at Columbia University Health Sciences · NIH-11537840 · Data updated 2026-11-12

This grant aims to understand why cognitive problems occur in people 65 and older who have prediabetes or type 2 diabetes, using data from a long-running diabetes study to identify what drives memory and thinking decline.

More s Disease research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionColumbia University Health Sciences
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 1, 2022
Project endAugust 31, 2027
Funding year2026
Award (this year)$15,685,993
NIH project number5U19AG078558-05
Project IDNIH-11537840 on NIH RePORTER

Who could benefit from this research

Could help

Older adults (mean age around 72) with prediabetes or type 2 diabetes who are participants or eligible for the DPPOS cohort.

Less likely to help

Individuals without prediabetes or type 2 diabetes or those not in the DPPOS cohort may not directly benefit from this research.

What this research studies

The project uses the Diabetes Prevention Program Outcomes Study cohort, which already follows older adults with prediabetes or type 2 diabetes, to study brain changes and cognitive function. It combines advanced Alzheimer’s disease and related dementia phenotyping with existing health data to look at factors like glucose control, metabolic issues, and vascular problems. Researchers will examine how medications like metformin, physical activity, and frailty influence cognitive outcomes, and how these relate to different brain pathologies. The goal is to clarify the mechanisms behind cognitive impairment in this high-risk group and identify targets for prevention or intervention.

Why it matters

Potential benefit: If successful, findings could guide personalized strategies to reduce dementia risk and preserve thinking and memory in older adults with prediabetes or type 2 diabetes.

How similar studies have gone: Prior studies show that metabolic and vascular factors contribute to cognitive decline in diabetes, but this project adds deeper AD/ADRD phenotyping in a well-characterized cohort, representing a novel and comprehensive approach.

Where this research is happening

  • Columbia University Health Sciences
    New York, United States
    Active

Researchers

  • Principal investigator: Luchsinger, Jose Alejandro — Columbia University Health Sciences
  • Study coordinator: Luchsinger, Jose Alejandro

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.